Results 231 to 240 of about 15,421,997 (282)
Artificial intelligence-based drug repurposing with electronic health record clinical corroboration: A case for ketamine as a potential treatment for amphetamine-type stimulant use disorder. [PDF]
AddictionGao Z +6 more
europepmc +1 more source
High‐Efficiency Deep Blue Single‐Gaussian Europium(II) Emitters and Their Emitter‐Host Interactions
Advanced Functional Materials, EarlyView.Crown‐ether ligands and carborate anions enable vacuum‐processable Eu(II) emitters with efficient single‐Gaussian deep‐blue luminescence. Combined photophysical and computational analyses reveal that excited‐electron confinement and steric shielding of the europium center jointly govern compatibility with OLED host materials, establishing molecular ...
Mahmoud Soleimani +8 more
wiley +1 more source
Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration. [PDF]
J Addict MedFrost MC, Coughlin LN, Zhang L, Lin LA.
europepmc +1 more source
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. [PDF]
J Addict Medeuropepmc +1 more source
Stimulant Drugs and Stimulant Use Disorder
Anesthesiology Clinics, 2023 The authors aim to summarize several key points of stimulant drugs and stimulant use disorder, including their indications, short-term and long-term adverse effects, current treatment strategies, and association with opioid medications. The global prevalence of stimulant use has seen annual increase in the last decade.
Wenyu Song +2 more
exaly +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Screen of drug use: Diagnostic accuracy for stimulant use disorder
Addictive Behaviors, 2021Stimulant misuse, overdose, and related deaths have increased dramatically. Identifying and referring individuals with stimulant use disorder to treatment may reduce misuse and overdose. This study validated the 2-item Screen of Drug Use (SoDU; Tiet et al., 2015) to screen for stimulant use disorder (and for cocaine and amphetamine use disorders) in a ...
Quyen Tiet
exaly +3 more sources
Child and Adolescent Psychiatric Clinics of North America, 2016
Compared with other illicit substances, stimulants are not commonly used by adolescents; however, they represent a serious concern regarding substance use among youths. This article uses methamphetamine as a model for stimulant use in adolescents; cocaine and prescription stimulants are also mentioned.
Taryn M, Park, William F, Haning
openaire +2 more sources
Compared with other illicit substances, stimulants are not commonly used by adolescents; however, they represent a serious concern regarding substance use among youths. This article uses methamphetamine as a model for stimulant use in adolescents; cocaine and prescription stimulants are also mentioned.
Taryn M, Park, William F, Haning
openaire +2 more sources
Use of Stimulants in Bipolar Disorder
Current Psychiatry Reports, 2017Several international guidelines indicate stimulants, including methylphenidate (MPH), amphetamines and derivatives, modafinil, and armodafinil among the second-third-line choices for bipolar depression. Efficacy of stimulants has been also reported for the management of residual depressive symptoms such as fatigue and sleepiness and for the management
Perugi, Giulio +3 more
openaire +3 more sources
Psychiatric Annals, 2018
Stimulant use disorder (SUD) is a significant cause of morbidity and mortality around the world. Stimulants are natural and synthetic compounds that include cocaine, methamphetamines, and prescription stimulants. It is very important for providers before prescribing the stimulants to recognize and understand their high potential for ...
Andres Avellaneda-Ojeda +3 more
openaire +1 more source
Stimulant use disorder (SUD) is a significant cause of morbidity and mortality around the world. Stimulants are natural and synthetic compounds that include cocaine, methamphetamines, and prescription stimulants. It is very important for providers before prescribing the stimulants to recognize and understand their high potential for ...
Andres Avellaneda-Ojeda +3 more
openaire +1 more source
Deep brain stimulation for psychostimulant use disorders
Journal of Neural Transmission, 2023Safe and effective therapeutics for psychostimulant use disorders remain elusive. Deep brain stimulation (DBS), which is FDA-approved for other indications, is a promising candidate for treating severe substance use disorders. We examine the clinical and preclinical evidence for DBS of the nucleus accumbens as a possible therapeutic option for cocaine ...
Sarah E. Swinford-Jackson +1 more
openaire +2 more sources